PRINCETON, NJ — (Marketwired) — 07/15/13 — in Mineola, N.Y., is fulfilling its vision of broadening perinatal technology from Labor & Delivery to the Post-Partum and Well Baby Nursery units, encompassing the full range of comprehensive obstetric (OB) needs from labor, birth to early infant care. The OB multi-department technology expansion was made possible with the complete perinatal charting and fetal monitoring system designed to bring obstetrical services to the highest level of patient care excellence.
is the global leader in applying real-time clinical decision support to perinatal systems. Its PeriCALM Plus solution includes , the only fetal surveillance solution that is both cleared by the U.S. Food and Drug Administration (FDA) and by the (NIH).
“PeriGen is unique in that its evidence-based research drives all of its perinatal product development. Their successful melding of scientific and technological innovation supports our goal to be a world-class health system of excellence in maternal/child care,” said Anthony Vintzileos, M.D., chair of the Department of Obstetrics and Gynecology at Winthrop-University Hospital and professor of Obstetrics, Gynecology and Reproductive Sciences at Stony Brook University, School of Medicine. Dr. Vintzileos is a published authority on electronic fetal monitoring and an award recipient of The Society for Maternal-Fetal Medicine recognizing his academic contributions.
Dr. Vintzileos explained that in evaluating other traditional perinatal systems Winthrop-s OB leaders quickly recognized the advantages of PeriGen-s PeriCALM Plus- real-time fetal heart rate pattern recognition and clinical decision support analysis capabilities, in addition to its easy interoperable interfacing with different application platforms including Siemens- Soarian enterprise electronic health record (EHR) system.
“We saw the value in PeriGen-s evidence-based software beyond charting and documentation in meeting our evolving needs managing the continuum of obstetric care,” he continued. “As a pioneer in obstetrical, maternity and gynecological services for more than a century, Winthrop has always had an abiding commitment to women-s healthcare. We are one of the busiest in the New York metropolitan area, with approximately 4,500 births each year.”
“Winthrop-University Hospital continues to demonstrate their leadership commitment to providing safer patient care by equipping its OB clinicians with the market-s most sophisticated, evidenced-based perinatal tool that scales smoothly to their growth needs at an affordable cost,” said Matt Sappern, PeriGen-s CEO. “We-re excited to support their expansion plans as well as their fetal heart rate research with PeriCALM Patterns.”
Founded in 1896 by a group of local physicians and concerned citizens, Long Island-s first voluntary hospital is a 591-bed university-affiliated medical center and New York State-designated Regional Trauma Center which offers sophisticated diagnostic and therapeutic care in virtually every specialty and subspecialty of medicine and surgery. Winthrop-University Hospital is a major regional healthcare resource with a deep commitment to medical education and research, offering a full complement of inpatient and outpatient services.
The Hospital employs 6,000 dedicated and caring individuals, including nearly 1,500 nurses and 1,525 full-time and voluntary attending medical staff. Winthrop offers a broad range of inpatient and outpatient programs and services for the newborn through the elderly, primarily from Nassau, Suffolk and Queens Counties on Long Island, in a dynamic, progressive environment.
PeriGen, Inc., is an innovative provider of fetal surveillance systems employing patented, pattern-recognition and obstetrics technologies that empower perinatal clinicians to make confident, real-time decisions about the mothers and babies in their care. PeriGen-s customer-centric team of clinicians and technologists builds the most advanced systems available to augment obstetric decision-making and improve communications among the clinical team at the point of care, while supporting data flow between healthcare IT systems.
PeriGen-s unique fetal surveillance products provide dynamic visual cues that direct clinicians to the most essential patient information displayed on the screen. Unlike legacy fetal monitoring devices and software from non-specialist companies, PeriGen Visual Cueing provides an instant view of the mother-s and baby-s current status and trends over time to avoid errors, increasing patient safety and reducing risk for clinicians and hospitals. For more information, please visit us at .
Angela Jenkins
Amendola Communications for PeriGen
720.859.6930
Suzanne Trajkoski
Marketing Director
609.228.8346
You must be logged in to post a comment Login